The COVID-19 pandemic has challenged supply chains everywhere. The delivery of billions of vaccine doses and therapies globally has put an increasingly large spotlight on the global pharmaceutical supply chain. Now more than ever, there is a heightened focus on the development and ensuing distribution of pharmaceutical products—including the solutions, expertise and collaboration needed to deliver temperature-sensitive vaccines from a manufacturer’s facility to all corners of the world, on-time and in the right condition.

Click here to read the entire article.